The results concerning circulating irisin levels in obese patients are still controversial, especially in the presence of metabolic dysfunction, i.e., dyslipidemia, type 2 diabetes mellitus (T2DM), and other components, which are also characterized by a chronic inflammatory state [42,43,44,45,46,47,48,49]. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.